Concepedia

Effect of Ravuconazole, a New Triazole Antifungal, in a Rat Intraabdominal Abscess Model

Hiroshige Mikamo, Xiang Yin, Yoh Hayasaki, Masaru Satoh, Teruhiko Tamaya

Chemotherapy · 2001 · 12 citations · 8 references

DOI

Abstract

Taking into consideration the antifungal spectrum of ravuconazole, which includes non-albicans Candida as well as C. albicans and Aspergillus, it is suggested that ravuconazole would be a good agent for the treatment of fungal peritonitis.

References

8

Experimental Intra-Abdominal Abscesses in Rats: Development of an Experimental Model

William M. Weinstein, Andrew B. Onderdonk, John G. Bartlett et al. · Infection and Immunity · 1974 · 334 citations · Full text

, , +10

Antimicrobial Therapy of Experimental Intraabdominal Sepsis

W.M. Weinstein, Andrew B. Onderdonk, J. G. Bartlett et al. · The Journal of Infectious Diseases · 1975 · 250 citations

In vitro studies with R 51,211 (itraconazole)

Ana Espinel-Ingroff, Smith Shadomy, Ronald J. Gebhart · Antimicrobial Agents and Chemotherapy · 1984 · 132 citations

, , +14

Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis

Dileep George, Peggy Miniter, Vincent T. Andriole · Antimicrobial Agents and Chemotherapy · 1996 · 92 citations · Full text

, , +13

Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses

P. Kujath, Carsten Boos, K. Lerch et al. · Infection · 1993 · 83 citations

, , +5